Temporal changes in characteristics and external validity of randomized controlled trials in older people from 2012

Estelle van Eijk1, Yanna M van der Spek1, Floor J A van Deudekom2

  • 1Section of Gerontology and Geriatrics, Department of Internal Medicine, Leiden University Medical Center, PO Box 9600, 2300 RC, Leiden, the Netherlands.

BMC Geriatrics
|May 24, 2023
PubMed
Abstract

Insights

Inclusion of older adults in clinical trials increased slightly between 2012 and 2019, with improved reporting of geriatric assessments. However, dedicated trials for older populations remain infrequent, necessitating further research efforts.

Area of Science:

  • Geriatric Medicine
  • Clinical Trial Methodology
  • Evidence-Based Practice

Background:

  • Older adults are underrepresented in clinical trials, with limited reporting of geriatric characteristics in past studies.
  • This review examines changes in the characteristics and external validity of randomized controlled trials (RCTs) involving older individuals between 2012 and 2019.

Approach:

  • A systematic review of PubMed-indexed RCTs published in 2019, comparing findings to identical reviews from 2012.
  • RCTs were categorized based on specific design for older populations (mean age ≥70 or age cutoff ≥55) or inclusion of a majority of older individuals (mean age ≥60).
  • Screening for the reporting of geriatric assessments was conducted for trials including a majority of older participants.

Key Points:

  • In 2019, 8% of RCTs were specifically designed for older people, a slight increase from 7% in 2012.
  • The proportion of trials including a majority of older participants rose from 22% in 2012 to 25% in 2019.
  • Reporting of geriatric assessments in trials with older adults increased significantly, from 34% in 2012 to 52% in 2019.

Conclusions:

  • While the proportion of RCTs specifically targeting older adults remains low, there has been a notable improvement in reporting geriatric assessment characteristics.
  • Continued efforts are crucial to enhance both the quantity and validity of clinical trials involving the older population.

Related Concept Videos

Longitudinal Research02:20

Longitudinal Research

Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...
12.0K
Longitudinal Studies01:26

Longitudinal Studies

Longitudinal studies are also widely used in other medical and social science fields. For instance, in cardiovascular research, they can monitor patients' health over decades to identify risk factors for heart disease, such as high cholesterol or smoking, and evaluate the long-term effectiveness of preventive measures. Similarly, in mental health studies, researchers might follow individuals from adolescence into adulthood to understand the development and progression of conditions like...
191
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
6.9K
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.1K
Regression Toward the Mean01:52

Regression Toward the Mean

Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when...
6.3K
Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
166